Absorbed dose to ovaries or uterus during a 131I-therapeutic of cancer or hyperthyroidism: comparison between in vivo measurements by TLD and calculations.
D005260:Female; D006111:Graves Disease / Q000532:radiotherapy*; D006801:Humans; D008954:Models, Biological; D010053:Ovary / Q000528:radiation effects*; D011829:Radiation Dosage; D013819:Thermoluminescent Dosimetry; D013964:Thyroid Neoplasms / Q000532:radiotherapy*; D014599:Uterus / Q000528:radiation effects*